Genomics

Founded in 1998 and headquartered in Cambridge, UK, Genomics is a private company operating at the intersection of genetics, data science, and healthcare. It has developed a proprietary platform powered by a massive harmonized multi-omic database to generate polygenic risk scores and disease predictions. The company commercializes its insights across four key verticals: Life Sciences (drug discovery), Healthcare (precision health), Employers (wellness), and Partners (insurance underwriting), positioning itself as a leader in predictive genomics for population health.

Proprietary platform powered by one of the world's largest harmonized multi-omic databases, generating advanced polygenic risk scores (PRS) and insights. Includes 'Mystra,' an agentic AI platform for drug discovery and target identification, grounded in causal biology.

Genomics competes with direct-to-consumer genetic firms (e.g., 23andMe, Color), diagnostic companies, and a growing number of AI-driven drug discovery platforms (e.g., Insitro, Recursion). Its differentiation lies in its specific focus on absolute disease risk prediction, its large proprietary database, its causal biology approach, and its diversified commercial model across life sciences, healthcare, and insurance.